Descriptor
| Cost Effectiveness | 1 |
| Drug Therapy | 1 |
| Epilepsy | 1 |
| Mental Retardation | 1 |
| Seizures | 1 |
Source
| Mental Retardation | 1 |
Author
| Coulter, David L. | 1 |
Publication Type
| Journal Articles | 1 |
| Opinion Papers | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewedCoulter, David L. – Mental Retardation, 1997
This commentary on a study comparing use of the brand-name drug Depakene with generic valproic acid to control seizures in people with mental retardation notes the importance of distinguishing between Depakene and Depakote, which is an enteric-coated formulation for which there is no generic form currently available. (DB)
Descriptors: Cost Effectiveness, Drug Therapy, Epilepsy, Mental Retardation
